Vault-13

Ikarian Capital, LLC

DALLAS, TX · CIK 1778253 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2020 · limited liability company

$610.9m reported value -12.6% vs Q1 2026
126positions
39.5%in top 10
27 new 18 added 29 reduced 28 sold out vs Q1 2026

Options: 13 call positions ($130.8m notional), 17 put positions ($186.5m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ABIVAX SA SPONSORED ADS ABVX ABVX 328,635 $43.4m7.10% 7.10% AddedShares held: Q3 2025 396.1k, Q4 2025 206.0k, Q1 2026 57.6k, Q2 2026 328.6k +271.0k +271,000 470.2%
2 KODIAK SCIENCES INC COM KOD KOD 1,059,730 $41.3m6.76% 6.76% ReducedShares held: Q3 2025 413.8k, Q4 2025 719.8k, Q1 2026 1.3m, Q2 2026 1.1m -206.1k -206,065 -16.3%
3 ALUMIS INC COM ALMS ALMS 870,548 $24.5m4.01% 4.01% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.2m, Q2 2026 870.5k -343.0k -343,000 -28.3%
4 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 72,842 $24.4m3.99% 3.99% AddedShares held: Q3 2025 28.6k, Q4 2025 86.6k, Q1 2026 71.6k, Q2 2026 72.8k +1.3k +1,261 1.8%
5 VAXCYTE INC COM PCVX PCVX 388,682 $22.6m3.70% 3.70% ReducedShares held: Q3 2025 311.7k, Q4 2025 378.7k, Q1 2026 428.7k, Q2 2026 388.7k -40.0k -40,000 -9.3%
6 ANI PHARMACEUTICALS INC COM ANIP ANIP 272,085 $22.5m3.69% 3.69% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 147.1k, Q2 2026 272.1k +125.0k +125,000 85.0%
7 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 478,500 $17.8m2.91% 2.91% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 461.2k, Q2 2026 478.5k +17.3k +17,253 3.7%
8 ARCUS BIOSCIENCES INC COM RCUS RCUS 504,559 $15.6m2.55% 2.55% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 504.6k
9 RELMADA THERAPEUTICS INC COM RLMD RLMD 2,148,359 $14.9m2.43% 2.43% ReducedShares held: Q3 2025 1.8m, Q4 2025 3.1m, Q1 2026 2.7m, Q2 2026 2.1m -540.0k -540,000 -20.1%
10 CAPRICOR THERAPEUTICS INC COM NEW CAPR CAPR 604,215 $14.5m2.38% 2.38% AddedShares held: Q3 2025 264.6k, Q4 2025 578.0k, Q1 2026 528.0k, Q2 2026 604.2k +76.2k +76,200 14.4%
11 COGENT BIOSCIENCES INC COM COGT COGT 370,084 $14.3m2.34% 2.34% NewShares held: Q3 2025 11.3k, Q4 2025 0, Q1 2026 0, Q2 2026 370.1k
12 VERA THERAPEUTICS INC CL A VERA VERA 310,000 $13.3m2.18% 2.18% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 200.0k, Q2 2026 310.0k +110.0k +110,000 55.0%
13 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 807,874 $13.2m2.17% 2.17% UnchangedShares held: Q3 2025 0, Q4 2025 282.9k, Q1 2026 807.9k, Q2 2026 807.9k
14 TENAX THERAPEUTICS INC COM NEW TENX TENX 787,600 $11.5m1.88% 1.88% ReducedShares held: Q3 2025 967.6k, Q4 2025 967.6k, Q1 2026 1.0m, Q2 2026 787.6k -230.0k -230,000 -22.6%
15 C4 THERAPEUTICS INC COM STK CCCC CCCC 2,433,000 $11.4m1.86% 1.86% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.4m
16 MAZE THERAPEUTICS INC COM MAZE MAZE 378,999 $11.3m1.85% 1.85% UnchangedShares held: Q3 2025 740.8k, Q4 2025 644.7k, Q1 2026 379.0k, Q2 2026 379.0k
17 BIOHAVEN LTD COM BHVN BHVN 748,181 $11.1m1.82% 1.82% AddedShares held: Q3 2025 0, Q4 2025 212.5k, Q1 2026 412.5k, Q2 2026 748.2k +335.7k +335,700 81.4%
18 CONNECT BIOPHARMA HLDGS LTD SHS CNTB CNTB 4,538,534 $10.8m1.77% 1.77% ReducedShares held: Q3 2025 0, Q4 2025 4.8m, Q1 2026 5.4m, Q2 2026 4.5m -850.0k -849,952 -15.8%
19 ALTO NEUROSCIENCE INC COM SHS ANRO ANRO 407,338 $10.7m1.76% 1.76% ReducedShares held: Q3 2025 110.0k, Q4 2025 515.0k, Q1 2026 515.0k, Q2 2026 407.3k -107.7k -107,662 -20.9%
20 PHARVARIS N V COM PHVS PHVS 308,856 $10.7m1.75% 1.75% ReducedShares held: Q3 2025 210.2k, Q4 2025 486.9k, Q1 2026 486.9k, Q2 2026 308.9k -178.0k -178,000 -36.6%
21 JADE BIOSCIENCES INC COM NEW JBIO JBIO 427,349 $9.5m1.55% 1.55% ReducedShares held: Q3 2025 0, Q4 2025 300.0k, Q1 2026 512.3k, Q2 2026 427.3k -85.0k -85,000 -16.6%
22 DAMORA THERAPEUTICS INC COM NEW COM NEW 335,710 $8.7m1.43% 1.43% UnchangedShares held: Q3 2025 0, Q4 2025 285.7k, Q1 2026 335.7k, Q2 2026 335.7k
23 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 425,000 $7.8m1.28% 1.28% NewShares held: Q3 2025 245.5k, Q4 2025 0, Q1 2026 0, Q2 2026 425.0k
24 PELTHOS THERAPEUTICS INC COM SHS PTHS PTHS 256,598 $7.3m1.19% 1.19% UnchangedShares held: Q3 2025 62.5k, Q4 2025 255.8k, Q1 2026 256.6k, Q2 2026 256.6k
25 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 1,218,492 $7.2m1.18% 1.18% AddedShares held: Q3 2025 2.1m, Q4 2025 802.3k, Q1 2026 1.2m, Q2 2026 1.2m +25.0k +25,000 2.1%
26 TECTONIC THERAPEUTIC INC COM TECX TECX 205,837 $7.1m1.16% 1.16% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 157.5k, Q2 2026 205.8k +48.3k +48,300 30.7%
27 SPRUCE BIOSCIENCES INC COM NEW SPRB SPRB 121,356 $6.6m1.07% 1.07% UnchangedShares held: Q3 2025 13.3k, Q4 2025 121.4k, Q1 2026 121.4k, Q2 2026 121.4k
28 HIMS & HERS HEALTH INC COM CL A HIMS HIMS 188,381 $6.5m1.07% 1.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 188.4k
29 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 126,541 $6.4m1.05% 1.05% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 126.5k
30 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 3,425,930 $6.4m1.04% 1.04% AddedShares held: Q3 2025 892.2k, Q4 2025 1.5m, Q1 2026 1.5m, Q2 2026 3.4m +1.9m +1,933,701 129.6%
31 BRIGHT MINDS BIOSCIENCES INC COM NEW DRUG DRUG 88,951 $6.2m1.02% 1.02% ReducedShares held: Q3 2025 15.4k, Q4 2025 159.4k, Q1 2026 166.6k, Q2 2026 89.0k -77.7k -77,696 -46.6%
32 OVID THERAPEUTICS INC COM OVID OVID 2,269,704 $6.1m1.00% 1.00% ReducedShares held: Q3 2025 1.1m, Q4 2025 247.6k, Q1 2026 2.9m, Q2 2026 2.3m -625.0k -625,000 -21.6%
33 OCUGEN INC COM OCGN OCGN 3,962,972 $6.1m0.99% 0.99% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.0m, Q2 2026 4.0m
34 ALPHA COGNITION INC COM NEW ACOG ACOG 836,259 $6.0m0.99% 0.99% ReducedShares held: Q3 2025 946.3k, Q4 2025 1.1m, Q1 2026 1.1m, Q2 2026 836.3k -220.0k -220,000 -20.8%
35 HARROW INC COM HROW HROW 135,775 $5.8m0.94% 0.94% ReducedShares held: Q3 2025 0, Q4 2025 183.3k, Q1 2026 543.0k, Q2 2026 135.8k -407.3k -407,272 -75.0%
36 KAZIA THERAPEUTICS LTD SPONSORED ADS KZIA KZIA 396,201 $5.6m0.91% 0.91% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 396.2k
37 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 165,617 $5.5m0.91% 0.91% ReducedShares held: Q3 2025 0, Q4 2025 12.7k, Q1 2026 482.6k, Q2 2026 165.6k -317.0k -316,954 -65.7%
38 Q32 BIO INC COM QTTB QTTB 430,000 $5.5m0.90% 0.90% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 430.0k
39 EUPRAXIA PHARMACEUTICALS INC COM EPRX EPRX 809,741 $5.4m0.88% 0.88% ReducedShares held: Q3 2025 0, Q4 2025 610.0k, Q1 2026 1.2m, Q2 2026 809.7k -405.0k -405,000 -33.3%
40 BIOAGE LABS INC COM BIOA BIOA 200,000 $4.9m0.80% 0.80% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 200.0k
41 REZOLUTE INC COM NEW RZLT RZLT 935,012 $4.9m0.80% 0.80% AddedShares held: Q3 2025 0, Q4 2025 16.5k, Q1 2026 16.5k, Q2 2026 935.0k +918.5k +918,533 5574.0%
42 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 383,281 $4.8m0.78% 0.78% ReducedShares held: Q3 2025 0, Q4 2025 758.7k, Q1 2026 598.3k, Q2 2026 383.3k -215.0k -215,000 -35.9%
43 MONOPAR THERAPEUTICS INC COM NEW MNPR MNPR 47,861 $4.4m0.73% 0.73% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 47.9k
44 BRIDGEBIO PHARMA INC COM BBIO BBIO 57,417 $4.3m0.70% 0.70% ReducedShares held: Q3 2025 52.0k, Q4 2025 0, Q1 2026 160.1k, Q2 2026 57.4k -102.7k -102,703 -64.1%
45 INVENTIVA SA ADS IVA IVA 1,129,101 $4.2m0.68% 0.68% ReducedShares held: Q3 2025 0, Q4 2025 502.6k, Q1 2026 1.4m, Q2 2026 1.1m -300.0k -300,000 -21.0%
46 ABSCI CORPORATION COM ABSI ABSI 353,772 $4.1m0.67% 0.67% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 353.8k
47 ALECTOR INC COM ALEC ALEC 1,982,606 $4.0m0.65% 0.65% ReducedShares held: Q3 2025 760.0k, Q4 2025 2.1m, Q1 2026 2.1m, Q2 2026 2.0m -100.0k -100,000 -4.8%
48 CLIMB BIO INC COM CLYM CLYM 300,000 $3.9m0.64% 0.64% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 300.0k
49 FULCRUM THERAPEUTICS INC COM FULC FULC 1,049,161 $3.8m0.63% 0.63% UnchangedShares held: Q3 2025 1.3m, Q4 2025 1.4m, Q1 2026 1.0m, Q2 2026 1.0m
50 CARDIOL THERAPEUTICS INC COM CL A CRDL CRDL 3,325,000 $3.5m0.58% 0.58% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.7m, Q2 2026 3.3m +600.0k +600,000 22.0%
51 CUE BIOPHARMA INC COM CUE CUE 104,364 $3.3m0.54% 0.54% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 104.4k
52 CUMBERLAND PHARMACEUTICALS I COM CPIX CPIX 503,153 $3.3m0.53% 0.53% ReducedShares held: Q3 2025 555.9k, Q4 2025 555.9k, Q1 2026 553.2k, Q2 2026 503.2k -50.0k -50,000 -9.0%
53 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 38,278 $3.1m0.51% 0.51% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 38.3k
54 REIN THERAPEUTICS INC COM NEW RNTX RNTX 2,950,000 $3.1m0.50% 0.50% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.0m
55 ARVINAS INC COM ARVN ARVN 358,257 $3.0m0.49% 0.49% UnchangedShares held: Q3 2025 226.3k, Q4 2025 358.3k, Q1 2026 358.3k, Q2 2026 358.3k
56 ACUMEN PHARMACEUTICALS INC COM ABOS ABOS 1,053,797 $2.8m0.46% 0.46% UnchangedShares held: Q3 2025 265.8k, Q4 2025 254.3k, Q1 2026 1.1m, Q2 2026 1.1m
57 PROMIS NEUROSCIENCES INC COM SHS PMN PMN 205,000 $2.7m0.44% 0.44% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 55.0k, Q2 2026 205.0k +150.0k +150,000 272.7%
58 ANNEXON INC COM ANNX ANNX 430,244 $2.5m0.40% 0.40% ReducedShares held: Q3 2025 0, Q4 2025 230.2k, Q1 2026 580.2k, Q2 2026 430.2k -150.0k -150,000 -25.9%
59 LEXEO THERAPEUTICS INC COM LXEO LXEO 513,011 $2.4m0.39% 0.39% UnchangedShares held: Q3 2025 567.6k, Q4 2025 513.0k, Q1 2026 513.0k, Q2 2026 513.0k
60 DELCATH SYS INC COM NEW DCTH DCTH 185,667 $2.3m0.38% 0.38% ReducedShares held: Q3 2025 431.3k, Q4 2025 431.3k, Q1 2026 431.3k, Q2 2026 185.7k -245.6k -245,584 -57.0%
61 INVIVYD INC COM IVVD IVVD 2,656,570 $2.3m0.38% 0.38% UnchangedShares held: Q3 2025 2.1m, Q4 2025 2.7m, Q1 2026 2.7m, Q2 2026 2.7m
62 CABALETTA BIO INC COM CABA CABA 700,000 $2.2m0.36% 0.36% ReducedShares held: Q3 2025 0, Q4 2025 900.0k, Q1 2026 900.0k, Q2 2026 700.0k -200.0k -200,000 -22.2%
63 NEUMORA THERAPEUTICS INC. COM NMRA NMRA 1,278,408 $2.2m0.36% 0.36% UnchangedShares held: Q3 2025 12.5k, Q4 2025 1.3m, Q1 2026 1.3m, Q2 2026 1.3m
64 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 117,500 $2.1m0.35% 0.35% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 117.5k
65 TARSUS PHARMACEUTICALS INC COM TARS TARS 31,166 $2.0m0.32% 0.32% UnchangedShares held: Q3 2025 73.6k, Q4 2025 31.2k, Q1 2026 31.2k, Q2 2026 31.2k
66 SILENCE THERAPEUTICS PLC ADS SLN SLN 830,784 $1.8m0.30% 0.30% ReducedShares held: Q3 2025 900.8k, Q4 2025 865.8k, Q1 2026 865.8k, Q2 2026 830.8k -35.0k -35,000 -4.0%
67 JOURNEY MED CORP COM DERM DERM 251,436 $1.8m0.29% 0.29% UnchangedShares held: Q3 2025 0, Q4 2025 251.4k, Q1 2026 251.4k, Q2 2026 251.4k
68 DBV TECHNOLOGIES S A SPONSORED ADS DBVT DBVT 525,000 $1.7m0.28% 0.28% UnchangedShares held: Q3 2025 0, Q4 2025 525.0k, Q1 2026 525.0k, Q2 2026 525.0k
69 IBIO INC COM NEW IBIO IBIO 957,062 $1.7m0.27% 0.27% UnchangedShares held: Q3 2025 617.3k, Q4 2025 957.1k, Q1 2026 957.1k, Q2 2026 957.1k
70 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 90,183 $1.7m0.27% 0.27% NewShares held: Q3 2025 159.8k, Q4 2025 31.1k, Q1 2026 0, Q2 2026 90.2k
71 ANTERIS TECHNOLOGIES GLOBAL COM AVR AVR 166,571 $1.6m0.27% 0.27% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 366.6k, Q2 2026 166.6k -200.0k -200,000 -54.6%
72 PALISADE BIO INC COM PALI PALI 750,000 $1.6m0.26% 0.26% AddedShares held: Q3 2025 0, Q4 2025 275.0k, Q1 2026 275.0k, Q2 2026 750.0k +475.0k +475,022 172.8%
73 AMANAT ACQUISITION CORP CL A ORD AMAN AMAN 150,000 $1.5m0.25% 0.25% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 150.0k
74 KALARIS THERAPEUTICS INC COM KLRS KLRS 360,000 $1.5m0.24% 0.24% UnchangedShares held: Q3 2025 0, Q4 2025 360.0k, Q1 2026 360.0k, Q2 2026 360.0k
75 QUINCE THERAPEUTICS INC COM IRLA IRLA 72,251 $1.3m0.22% 0.22% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 72.3k
76 LIPOCINE INC NEW COM NEW LPCN LPCN 508,556 $1.3m0.21% 0.21% UnchangedShares held: Q3 2025 0, Q4 2025 199.5k, Q1 2026 508.6k, Q2 2026 508.6k
77 IMMUNOME INC COM IMNM IMNM 60,000 $1.3m0.21% 0.21% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 60.0k
78 PLIANT THERAPEUTICS INC COM PLRX PLRX 1,000,000 $1.1m0.19% 0.19% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
79 IMMUNIC INC COM NEW IMUX IMUX 67,464 $1.0m0.17% 0.17% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 67.5k
80 QUOIN PHARMACEUTICALS LTD SPONSORED ADS QNRX QNRX 211,538 $1.0m0.17% 0.17% UnchangedShares held: Q3 2025 0, Q4 2025 211.5k, Q1 2026 211.5k, Q2 2026 211.5k
81 EQUILLIUM INC COM EQ EQ 303,555 $971.4k0.16% 0.16% UnchangedShares held: Q3 2025 332.3k, Q4 2025 303.6k, Q1 2026 303.6k, Q2 2026 303.6k
82 NEURONETICS INC COM STIM STIM 701,182 $911.5k0.15% 0.15% UnchangedShares held: Q3 2025 905.7k, Q4 2025 701.2k, Q1 2026 701.2k, Q2 2026 701.2k
83 FAETH THERAPEUTICS INC COM NEW FTH FTH 35,386 $884.6k0.14% 0.14% AddedShares held: Q3 2025 22.5k, Q4 2025 21.4k, Q1 2026 6.4k, Q2 2026 35.4k +29.0k +29,035 457.2%
84 FRACTYL HEALTH INC COM COM 1,100,000 $873.8k0.14% 0.14% UnchangedShares held: Q3 2025 1.8m, Q4 2025 1.1m, Q1 2026 1.1m, Q2 2026 1.1m
85 CYBIN INC COM NEW COM NEW 132,153 $873.5k0.14% 0.14% UnchangedShares held: Q3 2025 140.5k, Q4 2025 132.2k, Q1 2026 132.2k, Q2 2026 132.2k
86 FIRST TRACKS BIOTHERAPEUTICS ORD SHS TRAX TRAX 42,775 $860.6k0.14% 0.14% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 42.8k
87 VERASTEM INC COM NEW VSTM VSTM 213,865 $817.0k0.13% 0.13% UnchangedShares held: Q3 2025 0, Q4 2025 213.9k, Q1 2026 213.9k, Q2 2026 213.9k
88 DIREXION SHS ETF TR DAILY S&P BIOTEC LABD LABD 105,822 $815.9k0.13% 0.13% UnchangedShares held: Q3 2025 92.0k, Q4 2025 40.8k, Q1 2026 105.8k, Q2 2026 105.8k
89 PEPGEN INC COM PEPG PEPG 447,165 $804.9k0.13% 0.13% UnchangedShares held: Q3 2025 536.0k, Q4 2025 447.2k, Q1 2026 447.2k, Q2 2026 447.2k
90 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 28,099 $710.9k0.12% 0.12% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 28.1k, Q2 2026 28.1k
91 CNS PHARMACEUTICALS INC COM CNSP CNSP 135,830 $649.3k0.11% 0.11% AddedShares held: Q3 2025 0, Q4 2025 45.8k, Q1 2026 45.8k, Q2 2026 135.8k +90.0k +90,000 196.4%
92 LYELL IMMUNOPHARMA INC COM NEW LYEL LYEL 41,081 $577.2k0.09% 0.09% UnchangedShares held: Q3 2025 43.8k, Q4 2025 41.1k, Q1 2026 41.1k, Q2 2026 41.1k
93 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 85,285 $495.5k0.08% 0.08% UnchangedShares held: Q3 2025 96.0k, Q4 2025 85.3k, Q1 2026 85.3k, Q2 2026 85.3k
94 IMMATICS N.V SHS IMTX IMTX 48,569 $492.0k0.08% 0.08% UnchangedShares held: Q3 2025 49.4k, Q4 2025 48.6k, Q1 2026 48.6k, Q2 2026 48.6k
95 PASSAGE BIO INC COM NEW PASG PASG 99,517 $485.6k0.08% 0.08% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 68.1k, Q2 2026 99.5k +31.4k +31,393 46.1%
96 NEXTCURE INC COM NEW NXTC NXTC 288,303 $461.3k0.08% 0.08% AddedShares held: Q3 2025 0, Q4 2025 238.3k, Q1 2026 238.3k, Q2 2026 288.3k +50.0k +50,000 21.0%
97 FORTE BIOSCIENCES INC COM NEW FBRX FBRX 20,972 $445.7k0.07% 0.07% ReducedShares held: Q3 2025 300.0k, Q4 2025 300.0k, Q1 2026 119.0k, Q2 2026 21.0k -98.0k -98,000 -82.4%
98 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 42,956 $429.1k0.07% 0.07% ReducedShares held: Q3 2025 176.7k, Q4 2025 160.4k, Q1 2026 264.4k, Q2 2026 43.0k -221.5k -221,453 -83.8%
99 TRAWS PHARMA INC COM NEW TRAW TRAW 478,142 $403.2k0.07% 0.07% ReducedShares held: Q3 2025 28.5k, Q4 2025 678.1k, Q1 2026 678.1k, Q2 2026 478.1k -200.0k -200,000 -29.5%
100 LEXICON PHARMACEUTICALS INC COM NEW LXRX LXRX 164,674 $395.2k0.06% 0.06% UnchangedShares held: Q3 2025 176.5k, Q4 2025 164.7k, Q1 2026 164.7k, Q2 2026 164.7k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
TERNS PHARMACEUTICALS INC 1,456,378 $76.8m1.5m shares
CYTOKINETICS INC CYTK CYTK 283,572 $18.7m283.6k shares
REVOLUTION MEDICINES INC RVMD RVMD 163,142 $15.9m163.1k shares
ORUKA THERAPEUTICS INC ORKA ORKA 242,021 $11.9m242.0k shares
SOLENO THERAPEUTICS INC SLNO SLNO 344,123 $11.5m344.1k shares
IONIS PHARMACEUTICALS INC IONS IONS 127,038 $9.5m127.0k shares
PALVELLA THERAPEUTICS INC NE PVLA PVLA 64,626 $8.1m64.6k shares
ELI LILLY & CO LLY LLY 6,547 $6.0m6.5k shares
SURROZEN INC SRZN SRZN 173,107 $5.0m173.1k shares
LEGEND BIOTECH CORP LEGN LEGN 226,888 $4.1m226.9k shares
KARYOPHARM THERAPEUTICS INC KPTI KPTI 733,435 $4.1m733.4k shares
PERCEPTIVE CAP SOLUTIONS COR FRNM FRNM 240,951 $2.6m241.0k shares
VIR BIOTECHNOLOGY INC VIR VIR 293,258 $2.6m293.3k shares
BRIDGEBIO ONCOLOGY THERAPEUT BBOT BBOT 270,231 $2.4m270.2k shares
NUVALENT INC 23,594 $2.4m23.6k shares
JAZZ PHARMACEUTICALS PLC JAZZ JAZZ 12,460 $2.4m12.5k shares
UNIQURE NV QURE QURE 91,060 $1.5m91.1k shares
DEFINIUM THERAPEUTICS INC DFTX DFTX 58,803 $1.1m58.8k shares
KEZAR LIFE SCIENCES INC KZR KZR 102,211 $758.4k102.2k shares
IMMUNIC INC 674,662 $748.9k674.7k shares
CENTESSA PHARMACEUTICALS PLC 18,113 $719.4k18.1k shares
KALVISTA PHARMACEUTICALS INC KALV KALV 35,119 $706.9k35.1k shares
INSMED INC INSM INSM 4,214 $689.1k4.2k shares
SANGAMO THERAPEUTICS INC SGMOQ SGMOQ 1,218,671 $300.9k1.2m shares
VERU INC VERU VERU 133,517 $295.1k133.5k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR SER TR XBI · Put XBIPut 300,000 $47.5m300.0k shares Reduced
ABIVAX SA ABVX · Call ABVXCall 341,100 $45.5m341.1k shares Added
ABIVAX SA ABVX · Put ABVXPut 250,000 $33.3m250.0k shares New
IONIS PHARMACEUTICALS INC IONS · Call IONSCall 400,000 $31.7m400.0k shares Added
MODERNA INC MRNA · Put MRNAPut 400,000 $28.0m400.0k shares New
IONIS PHARMACEUTICALS INC IONS · Put IONSPut 300,000 $23.8m300.0k shares New
NEWAMSTERDAM PHARMA COMPANY NAMS · Put NAMSPut 400,000 $13.6m400.0k shares New
ALUMIS INC ALMS · Call ALMSCall 356,300 $10.0m356.3k shares Added
KODIAK SCIENCES INC KOD · Call KODCall 217,700 $8.5m217.7k shares Added
CAPRICOR THERAPEUTICS INC CAPR · Call CAPRCall 350,000 $8.4m350.0k shares Unchanged
ARROWHEAD PHARMACEUTICALS IN ARWR · Put ARWRPut 100,000 $8.2m100.0k shares Added
PRAXIS PRECISION MEDICINES I PRAX · Call PRAXCall 20,000 $6.7m20.0k shares New
KYMERA THERAPEUTICS INC KYMR · Put KYMRPut 50,400 $5.8m50.4k shares Unchanged
TENAX THERAPEUTICS INC TENX · Call TENXCall 373,100 $5.4m373.1k shares Added
EYEPOINT PHARMACEUTICALS INC EYPT · Put EYPTPut 370,400 $5.3m370.4k shares Unchanged
EYEPOINT PHARMACEUTICALS INC EYPT · Call EYPTCall 370,400 $5.3m370.4k shares Unchanged
SELLAS LIFE SCIENCES GROUP I SLS · Put SLSPut 354,700 $5.2m354.7k shares New
SIONNA THERAPEUTICS INC SION · Put SIONPut 107,500 $4.7m107.5k shares New
CELLDEX THERAPEUTICS INC NEW CLDX · Put CLDXPut 114,000 $4.2m114.0k shares Unchanged
VERA THERAPEUTICS INC VERA · Call VERACall 71,700 $3.1m71.7k shares Unchanged
Q32 BIO INC QTTB · Put QTTBPut 200,000 $2.5m200.0k shares New
OLEMA PHARMACEUTICALS INC OLMA · Call OLMACall 200,000 $2.5m200.0k shares Reduced
BRISTOL-MYERS SQUIBB CO BMY · Put BMYPut 42,500 $2.4m42.5k shares Reduced
UNIQURE NV QURE · Call QURECall 49,800 $2.3m49.8k shares Reduced
DISC MEDICINE INC IRON · Put IRONPut 13,300 $972.8k13.3k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
NEXTCURE INC NXTC · 13G · filed 2026-08-14 NXTC 10.0%≈ $804.3k no change 13G 2026-08-14
CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-08-14 CNSP 9.9%≈ $704.0k +4.2 pts 13G 2026-08-14
TRAWS PHARMA INC TRAW · 13G · filed 2026-08-14 TRAW 9.5%≈ $1.3m -0.5 pts 13G 2026-08-14
QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 IRLA 9.0%≈ $1.7m new 13G 2026-08-14
PELTHOS THERAPEUTICS INC PTHS · 13G · filed 2026-05-15 PTHS 7.7%≈ $7.3m -0.7 pts 13G 2026-05-15
CHANNEL THERAPEUTICS CORPORA 13G · filed 2025-02-14 7.3% new 13G 2025-02-14
CONNECT BIOPHARMA HLDGS LTD 13G · filed 2026-08-14 6.9% -1.9 pts 13G 2026-08-14
LIPOCINE INC NEW LPCN · 13G · filed 2026-05-15 LPCN 6.3% new 13G 2026-05-15